Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01920178 · ClinicalTrials.gov registry record · NA
Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis
A NA study, sponsored by Cambridge Health Alliance.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01920178 is a NA study that was terminated before completion, run by Cambridge Health Alliance. The registered enrollment target is 7 participants.
The verdict
NCT01920178, a NA study, was terminated before completion, sponsored by Cambridge Health Alliance.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the clinical efficacy and safety of the PinPointe Foot Laser device for the treatment of patients with onychomycosis who have been previously treated with oral Terbinafine and failed.
Interventions
- DEVICE PinPointe Foot Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01920178
The ClinicalTrials.gov registry entry for NCT01920178 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PinPointe Foot Laser is the first listed.
NCT01920178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01920178 about?
NCT01920178 is a clinical study titled "Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis". The purpose of this study is to assess the clinical efficacy and safety of the PinPointe Foot Laser device for the treatment of patients with onychomycosis who have been previously treated with oral Terbinafine and failed.
What is the current status of trial NCT01920178?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2013-04. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01920178?
The interventions under investigation include: PinPointe Foot Laser (DEVICE).
Who is sponsoring clinical trial NCT01920178?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.